INVE's advanced technologies/products such as contact and contactless smart cards, tokens embedded in mobile phones and tablets, NFC cashless payments and identity as a service (IaaS) or cloud-based identity management solutions are growing exponentially.
The company's new CEO Jason Hart is selling unprofitable divisions and focusing on nigh-growth areas.
The most impressive growth is being seen in NFC transponders for machine-to-machine applications, electronic games, and mobile phone-based applications. The company expects a significant demand for its NFC products in the second half of 2013 for applications in games compatible with Xbox, Playstations, etc. In 2Q 2013 the company reported that they shipped 46 million transponders bringing 1H 2013 shipments on par with full year 2012 shipments.
The divisions the company is selling will only reduce revenues by about $5 million out of over $100 million total. These divisions will likely fetch more than $6 million according to analysts. This will strenghten the balance sheet and increase working capital.
New CEO Jason Hart, 42, is a 25-year veteran of the technology industry with a substantial track record of innovation and success, including more than 20 years leading security companies. Hart joined Identive in 2011 following the acquisition of idOnDemand, a company he co-founded that pioneered the delivery of smart card-based identity solutions via a cloud service. Prior to idOnDemand, he served as CEO and director of ActivIdentity, a publicly-traded provider of identity assurance and strong authentication solutions. Hart joined Actividentity in 2005 through the acquisition of Protocom Development Systems, Inc., an identity management software security business that he founded and led as CEO. He has been listed in Business Week's Top CEOs Under 40 and was named 2002 Ernst & Young 'Entrepreneur of the Year'
Latest: DSS (with only 46 M outstanding shares) filed patent-infringement lawsuit against AAPL in November - Will TWTR be next??.....very likely according to my sources.
- DSS filed in 2012 patent-infringement lawsuits against several companies including Facebook and LinkedIn for violating DSS-owned Bascom Patents. The Bascom Patents are believed to be the foundation/cornerstone of social networks as we know them now.
- Three companies have already settled with DSS. Broadvision and Jive Software will pay 4% to 5% royalties to DSS for the use of the Bascom patents. Novell settled out of court but terms are not known
- In conservative 2012 Facebook revenues of $5.1 billion 4% and 5% royalty rates fro DSS would amount to about $204 million and $254 million respectively. From public information 60% goes to DSS and the rest to the inventor/lawyer.
- DSS contends that Facebook & LinkedIn should pay from years they've used the technology until the patents expire in 2022.
- The U.S. District Court for the Northern District of California has set the Markman hearing date for February 26, 2014 for DSS, Inc. v. Facebook, Inc., and LinkedIn, Corp
- VHC went from under $2 to over $40 when it sued AAPL and won.
- DSS has a fast growing core business consisting of cloud-based and conventional high-technology suite of products for document securtity and counterfeiting. DSS is anot a typical "patent troll"
BACKGROUND - DSS owns a patent portfolio of six patents and four pending patent applications relating to technology invented by Thomas Bascom. DSS asserts that the Bascom Patents form the underlying architecture for the explosion of social networks by enabling users to link, search and provide selective access to information. These features are basic and fundamental for the frameworks that operates Facebook (FB), LinkedIn (LNKD), etc
SeekingAlpha uncovered three significant recent developments that sent the stock flying. Market cap is still only $20M after today's gain. The float is 8 Million shares and insiders have been buying like there is no tomorrow:
Recent but Significant DYSL news that investors were not aware of:
1) October 10, 2013. DSL forms of a new biotech subsidiary in partnership with the Mayo Clinic and enters a fast-growth global $4.5 billion biomedical market,The DYSL/Mayo Clinic's Xcede Patch is an advanced patch used to control bleeding. DYSL provides the technology and the Mayo clinic will provide funding as well as clinical trial expertise
2) November 19, 2013. DYSL gets a $4 million grant from the Department of Energy, - large government contracts/grants continue to feed the pipeline.
3) US approves of the company's new Navigator 2.0™ medical probe for cancer surgery. DYSL is pursuing European approval and expects international sales to begin in the near future